Summary

Eligibility
for people ages 21-85 (full criteria)
Location
at San Francisco, California
Dates
study started
estimated completion

Description

Summary

This is an observational study to evaluate the agreement between the InCardia diagnostic technology CorWatch for the assessment of venous pressure in human subjects. This includes evaluation of InCardia technology in heart failure (HF) patients undergoing invasive right heart catheterization in a cardiac catheterization laboratory (cath lab) and in a cardiac intensive care unit (ICU).

Official Title

Comparison of the InCardia Venous Pressure Diagnostic Technology CorWatch With Swan Ganz Catheter Measurements in the Cardiac Catheterization Laboratory and Cardiac Intensive Care Unit

Keywords

Heart Failure central venous pressure right heart catheterization hemodynamic congestion CorWatch

Eligibility

You can join if…

Open to people ages 21-85

  • Diagnosed with NYHA class II-IV heart failure irrespective of ejection fraction
  • Patient is able to give consent

You CAN'T join if...

  • Severe tricuspid regurgitation
  • Mechanical ventilation
  • Patient is pregnant
  • Inability to access either of the patient's upper arms.

Location

  • University of California San Francisco
    San Francisco California 94143 United States

Details

Status
accepting new patients by invitation only
Start Date
Completion Date
(estimated)
Sponsor
InCardia Inc.
ID
NCT04928326
Study Type
Observational
Last Updated